184 related articles for article (PubMed ID: 33730368)
1. Dupilumab for the treatment of recalcitrant eosinophilic dermatosis of haematologic malignancy.
Maglie R; Ugolini F; De Logu F; Simi S; Senatore S; Montefusco F; Nassini R; Massi D; Antiga E
J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):e501-e503. PubMed ID: 33730368
[No Abstract] [Full Text] [Related]
2. Efficacy of dupilumab in eosinophilic dermatosis of haematologic malignancy (EDHM) needs to be confirmed.
Sibaud V; Brun A; Meyer N; Oberic L; Lamant L; Ysebaert L
J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):e213-e215. PubMed ID: 34657337
[No Abstract] [Full Text] [Related]
3. Targeted inhibition of IL-4/13 with dupilumab is an effective treatment for eosinophilic dermatosis of hematologic malignancy.
Goyal A; Lofgreen S; Mariash E; Bershow A; Gaddis KJ
Dermatol Ther; 2020 Jul; 33(4):e13725. PubMed ID: 32558294
[No Abstract] [Full Text] [Related]
4. Hematologic-Related Malignancy-Induced Eosinophilic Dermatosis (He Remained): An eosinophilic dermatosis predominantly associated with chronic lymphocytic leukemia.
Cohen PR
J Am Acad Dermatol; 2020 Jan; 82(1):e13-e14. PubMed ID: 31473296
[No Abstract] [Full Text] [Related]
5. Response to: "Hematologic-Related Malignancy-Induced Eosinophilic Dermatosis (He Remained): An eosinophilic dermatosis predominantly associated with chronic lymphocytic leukemia".
Maglie R; Grandi V; Antiga E
J Am Acad Dermatol; 2020 Jan; 82(1):e15-e16. PubMed ID: 31473299
[No Abstract] [Full Text] [Related]
6. Flame figures associated with eosinophilic dermatosis of hematologic malignancy: is it possible to distinguish the condition from eosinophilic cellulitis in patients with hematoproliferative disease?
Qiao J; Sun CE; Zhu W; Zhu D; Fang H
Int J Clin Exp Pathol; 2013; 6(8):1683-7. PubMed ID: 23923089
[TBL] [Abstract][Full Text] [Related]
7. What's in a name? a new nomenclature has been proposed For eosinophilic dermatosis of hematologic malignancy (EDHM): hematologic-related malignancy-induced eosinophilic dermatosis (He Remained).
Cohen PR
Dermatol Online J; 2020 Jun; 26(6):. PubMed ID: 32815699
[TBL] [Abstract][Full Text] [Related]
8. Eosinophilic dermatosis of hematologic malignancy.
Farber MJ; La Forgia S; Sahu J; Lee JB
J Cutan Pathol; 2012 Jul; 39(7):690-5. PubMed ID: 22612903
[TBL] [Abstract][Full Text] [Related]
9. Eosinophilic dermatosis of haematological malignancy.
Jayasekera PS; Bakshi A; Al-Sharqi A
Clin Exp Dermatol; 2016 Aug; 41(6):692-5. PubMed ID: 27378400
[No Abstract] [Full Text] [Related]
10. Eosinophilic dermatosis of hematologic malignancy responding to dupilumab in a patient with chronic lymphocytic leukemia.
Jin A; Pousti BT; Savage KT; Mollanazar NK; Lee JB; Hsu S
JAAD Case Rep; 2019 Sep; 5(9):815-817. PubMed ID: 31508473
[No Abstract] [Full Text] [Related]
11. Eosinophilic dermatosis of hematologic malignancy: Correlation of molecular characteristics of skin lesions and extracutaneous manifestations of hematologic malignancy.
Meiss F; Technau-Hafsi K; Kern JS; May AM
J Cutan Pathol; 2019 Mar; 46(3):175-181. PubMed ID: 30411384
[TBL] [Abstract][Full Text] [Related]
12. Eosinophilic dermatosis of hematologic malignancy mimicking varicella zoster infection: report in a woman with chronic lymphocytic leukemia and review of the literature.
Bari O; Cohen PR
Dermatol Pract Concept; 2017 Jul; 7(3):6-15. PubMed ID: 29085714
[TBL] [Abstract][Full Text] [Related]
13. Eosinophilic Dermatosis of Malignancy Involving the Eyelid.
Ho TC; Compton L; Sheinbein D; Custer PL
Ophthalmic Plast Reconstr Surg; 2021 Nov-Dec 01; 37(6):e196-e198. PubMed ID: 34269770
[TBL] [Abstract][Full Text] [Related]
14. Eosinophilic Dermatosis of Hematologic Malignancy.
Lucas-Truyols S; Rodrigo-Nicolás B; Lloret-Ruiz C; Quecedo-Estébanez E
Actas Dermosifiliogr; 2017; 108(6):e39-e44. PubMed ID: 28342533
[TBL] [Abstract][Full Text] [Related]
15. Eosinophilic dermatosis of hematologic malignancy.
Martires K; Callahan S; Terushkin V; Brinster N; Leger M; Soter NA
Dermatol Online J; 2016 Dec; 22(12):. PubMed ID: 28329554
[TBL] [Abstract][Full Text] [Related]
16. Eosinophilic dermatosis of hematologic malignancy effectively controlled with omalizumab maintenance therapy.
Lor M; Gates G; Yu Y
Dermatol Ther; 2020 Nov; 33(6):e14206. PubMed ID: 32816408
[TBL] [Abstract][Full Text] [Related]
17. Eosinophilic dermatosis of hematologic malignancy: Reality bites.
Heymann WR
J Am Acad Dermatol; 2019 Jul; 81(1):74-75. PubMed ID: 31059721
[No Abstract] [Full Text] [Related]
18. Highlights in chronic lymphocytic leukemia from the 60th American Society of Hematology Annual Meeting.
Clin Adv Hematol Oncol; 2019 Jan; 17 Suppl 1(1):1-24. PubMed ID: 31545307
[No Abstract] [Full Text] [Related]
19. A Case of Eosinophilic Dermatosis of Hematologic Malignancy Treated With Narrow-Band Ultraviolet B (NBUVB).
Pan S; Bicknell L
Cureus; 2023 Mar; 15(3):e35734. PubMed ID: 37016657
[TBL] [Abstract][Full Text] [Related]
20. Successful use of venetoclax for treatment of eosinophilic dermatosis of myeloproliferative disease in a patient with chronic lymphocytic leukemia.
Peringeth G; Sundaram S; Bogner P; Conroy E; Torka P
Ann Hematol; 2020 May; 99(5):1129-1131. PubMed ID: 32193627
[No Abstract] [Full Text] [Related]
[Next] [New Search]